Outcomes of second allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia

BACKGROUND: Relapse after allogeneic hematopoietic cell transplantation (HCT) leads to poor survival in patients with acute myeloid leukemia (AML). A second HCT (HCT2) may achieve durable remission. OBJECTIVES: To determine the outcomes of patients who received an HCT2 for relapsed AML and to evalua...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Transplant Cell Ther
Autori principali: Yalniz, Fevzi F., Saliba, Rima M., Greenbaum, Uri, Ramdial, Jeremy, Popat, Uday, Oran, Betul, Alousi, Amin, Olson, Amanda, Alatrash, Gheath, Marin, David, Rezvani, Katy, Hosing, Chitra, Im, Jin, Mehta, Rohtesh, Qazilbash, Muzaffar, Joseph, Jacinth Joy, Rondon, Gabriela, Kanagal-Shamanna, Rashmi, Shpall, Elizabeth, Champlin, Richard, Kebriaei, Partow
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8316329/
https://ncbi.nlm.nih.gov/pubmed/34023569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtct.2021.05.007
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi